Half of new pharmaceuticals are pfas for example, lipitor, xanax, flonase, etc.
The EPA move came after the agency determined that types of PFAS created during the fluorination process “are highly toxic and present unreasonable risks that cannot be prevented other than through prohibition of manufacture.”
so using some legal loophole to work around the EPA in this case seems pretty "bad", no?
To the extent any PFAS remains present, independent testing has verified that in treating 25 million pounds of plastic packaging articles annually, Inhance’s fluorination process forms less than 15 grams – equivalent to the weight of a few grapes – of PFAS impurities. That amount represents less than 0.00000002% of the approximately 85,000 tons of PFAS generated domestically by other industries every year. Nonetheless, Inhance continues to conduct research and identify additional treatment modifications to further reduce and eliminate PFAS impurities from the fluorination process.
obviously they have a lot of bias and financial interest in this topic but it would be interesting to learn what the real deal is